These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9651157)

  • 21. Identification of side chains on 1,2,5-thiadiazole-azacycles optimal for muscarinic m1 receptor activation.
    Sauerberg P; Jeppesen L; Olesen PH; Sheardown MJ; Fink-Jensen A; Rasmussen T; Rimvall K; Shannon HE; Bymaster FP; DeLapp NW; Calligaro DO; Ward JS; Whitesitt CA; Thomsen C
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2897-902. PubMed ID: 9873644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.
    Lainé DI; Wan Z; Yan H; Zhu C; Xie H; Fu W; Busch-Petersen J; Neipp C; Davis R; Widdowson KL; Blaney FE; Foley J; Bacon AM; Webb EF; Luttmann MA; Burman M; Sarau HM; Salmon M; Palovich MR; Belmonte K
    J Med Chem; 2009 Aug; 52(16):5241-52. PubMed ID: 19630384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity studies of a series of 1-oxa-8-azaspiro[4.5]decanes as M1 muscarinic agonists.
    Tsukamoto S; Fujii M; Yasunaga T; Matsuda K; Wanibuchi F; Hidaka K; Furuya T; Tamura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):842-52. PubMed ID: 7553970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a high-affinity allosteric enhancer at muscarinic M1 receptors.
    Lazareno S; Popham A; Birdsall NJ
    J Mol Neurosci; 2002; 19(1-2):123-7. PubMed ID: 12212769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of a highly potent, functionally-selective muscarinic M1 agonist, WAY-132983 using rational drug design and receptor modelling.
    Sabb AL; Husbands GM; Tokolics J; Stein RP; Tasse RP; Boast CA; Moyer JA; Abou-Gharbia M
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1895-900. PubMed ID: 10450949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functionally selective M1 muscarinic agonists. 3. Side chains and azacycles contributing to functional muscarinic selectivity among pyrazinylazacycles.
    Ward JS; Merritt L; Calligaro DO; Bymaster FP; Shannon HE; Sawyer BD; Mitch CH; Deeter JB; Peters SC; Sheardown MJ; Olesen PH; Swedberg MD; Sauerberg P
    J Med Chem; 1995 Sep; 38(18):3469-81. PubMed ID: 7658434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and pharmacological characterization of O-alkynyloximes of tropinone and N-methylpiperidinone as muscarinic agonists.
    Xu R; Sim MK; Go ML
    J Med Chem; 1998 Aug; 41(17):3220-31. PubMed ID: 9703467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of CI-1002 and CI-1017 on spontaneous synaptic activity and on the nicotinic acetylcholine receptor of Torpedo electric organ.
    Ros E; Aleu J; Marsal J; Solsona C
    Eur J Pharmacol; 2000 Feb; 390(1-2):7-13. PubMed ID: 10708701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M
    Dallagnol JCC; Khajehali E; van der Westhuizen ET; Jörg M; Valant C; Gonçalves AG; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2018 Apr; 61(7):2875-2894. PubMed ID: 29544056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
    Olianas MC; Maullu C; Onali P
    Neuropsychopharmacology; 1999 Mar; 20(3):263-70. PubMed ID: 10063486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.
    Suzuki T; Uesaka H; Hamajima H; Ikami T
    Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):876-9. PubMed ID: 10399839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
    Ehlert FJ; Griffin MT; Glidden PF
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C(8) substituted 1-azabicyclo[3.3.1]non-3-enes and C(8) substituted 1-azabicyclo[3.3.1]nonan-4-ones: novel muscarinic receptor antagonists.
    Kim MG; Bodor ET; Wang C; Harden TK; Kohn H
    J Med Chem; 2003 May; 46(11):2216-26. PubMed ID: 12747793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 5-(4-alkylsulfanyl-[1, 2, 5]thiadiazol-3-yl)-3-methyl-1, 2, 3, 4-tetrahydropyrimidine oxalate salts and their evaluation as muscarinic receptor agonists.
    Jung MH; Park JG; Park WK
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):230-5. PubMed ID: 12916057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M
    Popiolek M; Nguyen DP; Reinhart V; Edgerton JR; Harms J; Lotarski SM; Steyn SJ; Davoren JE; Grimwood S
    Biochemistry; 2016 Dec; 55(51):7073-7085. PubMed ID: 27958713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons.
    Weiss C; Preston AR; Oh MM; Schwarz RD; Welty D; Disterhoft JF
    J Neurosci; 2000 Jan; 20(2):783-90. PubMed ID: 10632607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
    Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
    Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
    Wood MD; Murkitt KL; Ho M; Watson JM; Brown F; Hunter AJ; Middlemiss DN
    Br J Pharmacol; 1999 Apr; 126(7):1620-4. PubMed ID: 10323594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agonist potency ratios at m1 and m3 muscarinic receptors expressed in A9L and CHO cells.
    Richards MH
    Ann N Y Acad Sci; 1997 May; 812():165. PubMed ID: 9214278
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands.
    De Amici M; Conti P; Fasoli E; Barocelli E; Ballabeni V; Bertoni S; Impicciatore M; Roth BL; Ernsberger P; De Micheli C
    Farmaco; 2003 Sep; 58(9):739-48. PubMed ID: 13679167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.